While increasing technological innovation can aid companies in their HIPAA compliance practices, it can also create entirely new challenges. Join us as Edward Naughton breaks down what early-stage life sciences companies should know about HIPAA, and how they can rise to meet the complications presented by increased utilization of technology in the scientific world.